Thomas Sciascia
Fondatore presso TREVI THERAPEUTICS, INC.
Patrimonio netto: 529 455 $ in data 30/04/2024
Posizioni attive di Thomas Sciascia
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TREVI THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2011 | - |
| Fondatore | 01/01/2011 | - |
Storia della carriera di Thomas Sciascia
Precedenti posizioni note di Thomas Sciascia
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2000 | 01/01/2001 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 | 01/01/2000 |
| Boston University | Corporate Officer/Principal | 01/01/1983 | 01/01/1997 |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Direttore Tecnico/Scientifico/R&S | 01/03/2001 | - |
Formazione di Thomas Sciascia
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Thomas Sciascia
- Esperienza
